Hyperlipidemia is a major cardiovascular risk factor associated with progressive cerebrovascular dysfunction and diminished collateral perfusion in stroke. Rho-associated kinase (ROCK) may be an important mediator of hyperlipidemic vascular dysfunction. We tested the efficacy of acute or chronic ROCK inhibition on the size of dynamic perfusion defect using laser speckle flowmetry in hyperlipidemic apolipoprotein E knockout mice fed on a high-fat diet for 8 weeks. Mice were studied at an age before the development of flow-limiting atherosclerotic stenoses in aorta and major cervical arteries. Focal ischemia was induced by distal middle cerebral artery occlusion (dMCAO) during optical imaging. The ROCK inhibitor fasudil (10 mg/kg) was administered either as a single dose 1 hour before ischemia onset, or daily for 4 weeks. Fasudil decreased both baseline arterial blood pressure and cerebrovascular resistance (CVR) by B15%, and significantly improved tissue perfusion during dMCAO. Interestingly, peri-infarct depolarizations were also reduced. Chronic treatment did not further enhance these benefits compared with acute treatment with a single dose. These data show that ROCK inhibition improves CVR and ischemic tissue perfusion in hyperlipidemic mice. Keywords: ApoE knockout; distal middle cerebral artery occlusion; fasudil; hydroxyfasudil; hyperlipidemia; laser speckle flowmetry INTRODUCTION Hyperlipidemia is among the most prevalent vascular risk factors associated with stroke. Vascular endothelial and smooth muscle dysfunction has been shown in hyperlipidemic animal models as well as in patients. 1,2 In cerebral vasculature, hyperlipidemia impairs endothelium-dependent relaxations, 3 diminishes resting perfusion, and blunts major vasodilator reflexes, such as neurovascular coupling, hypercapnic hyperemia, and autoregulation. 4 We have recently shown that hyperlipidemic vascular dysfunction is associated with markedly larger perfusion defects on focal cerebral arterial occlusion. 4 A large body of evidence suggests that upregulation of Rho-associated kinase (ROCK) activity is one mechanism by which hyperlipidemia leads to vascular dysfunction. [5][6][7][8] Numerous studies have also shown that ROCK inhibition improves stroke outcome in otherwise normal animals, 9 and that the mechanism involves endothelium-dependent improvement in ischemic tissue perfusion presumably by augmenting the collateral blood supply. 10 Because hyperlipidemia is associated with upregulation of ROCK activity, we tested the efficacy of ROCK inhibitors in improving cortical perfusion on focal arterial occlusion in hyperlipidemic apolipoprotein E knockout (ApoE KO) mice.
Journal of Cerebral